BNP Paribas Exane Cuts Clorox (NYSE:CLX) Price Target to $95.00

by · The Markets Daily

Clorox (NYSE:CLX – Free Report) had its target price reduced by BNP Paribas Exane from $97.00 to $95.00 in a report issued on Monday morning,Benzinga reports. They currently have a neutral rating on the stock.

CLX has been the subject of a number of other reports. Jefferies Financial Group cut their price objective on Clorox from $139.00 to $125.00 and set a “buy” rating for the company in a research report on Monday, May 4th. Royal Bank Of Canada decreased their target price on shares of Clorox from $132.00 to $127.00 and set a “sector perform” rating on the stock in a research report on Thursday, April 9th. UBS Group increased their target price on shares of Clorox from $96.00 to $100.00 and gave the stock a “neutral” rating in a research note on Thursday, July 16th. JPMorgan Chase & Co. dropped their price target on shares of Clorox from $95.00 to $92.00 and set an “underweight” rating for the company in a research report on Thursday, July 16th. Finally, Zacks Research downgraded shares of Clorox from a “hold” rating to a “strong sell” rating in a research note on Tuesday, May 12th. One equities research analyst has rated the stock with a Buy rating, eleven have assigned a Hold rating and five have given a Sell rating to the company. According to data from MarketBeat, Clorox currently has an average rating of “Reduce” and a consensus price target of $103.60.

View Our Latest Stock Report on CLX

Clorox Trading Up 0.0%

CLX opened at $95.72 on Monday. The stock has a market capitalization of $11.57 billion, a PE ratio of 15.54 and a beta of 0.54. Clorox has a one year low of $84.70 and a one year high of $132.03. The company has a debt-to-equity ratio of 27.03, a quick ratio of 0.65 and a current ratio of 0.84. The business’s 50 day moving average price is $94.94 and its 200 day moving average price is $103.94.

Clorox (NYSE:CLX – Get Free Report) last posted its earnings results on Thursday, April 30th. The company reported $1.64 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.55 by $0.09. Clorox had a return on equity of 443.64% and a net margin of 11.18%.The company had revenue of $1.67 billion during the quarter, compared to analysts’ expectations of $1.67 billion. During the same quarter last year, the firm earned $1.45 earnings per share. The firm’s quarterly revenue was up .1% compared to the same quarter last year. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. As a group, equities research analysts expect that Clorox will post 5.52 EPS for the current year.

Insider Transactions at Clorox

In other news, Director Pierre R. Breber bought 5,000 shares of the firm’s stock in a transaction that occurred on Tuesday, May 5th. The shares were purchased at an average price of $85.82 per share, with a total value of $429,100.00. Following the purchase, the director owned 18,000 shares in the company, valued at approximately $1,544,760. The trade was a 38.46% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Insiders own 0.63% of the company’s stock.

Institutional Trading of Clorox

A number of institutional investors and hedge funds have recently bought and sold shares of the business. Haverford Trust Co boosted its holdings in Clorox by 2.8% in the fourth quarter. Haverford Trust Co now owns 3,070 shares of the company’s stock valued at $310,000 after purchasing an additional 84 shares in the last quarter. Field & Main Bank raised its holdings in Clorox by 3.3% during the fourth quarter. Field & Main Bank now owns 3,100 shares of the company’s stock worth $313,000 after purchasing an additional 100 shares in the last quarter. Golden State Wealth Management LLC raised its holdings in Clorox by 28.2% during the fourth quarter. Golden State Wealth Management LLC now owns 454 shares of the company’s stock worth $46,000 after purchasing an additional 100 shares in the last quarter. Kestra Private Wealth Services LLC lifted its position in shares of Clorox by 1.8% during the 1st quarter. Kestra Private Wealth Services LLC now owns 5,957 shares of the company’s stock worth $617,000 after buying an additional 104 shares during the last quarter. Finally, Johnson Financial Group Inc. lifted its position in shares of Clorox by 3.1% during the 3rd quarter. Johnson Financial Group Inc. now owns 3,659 shares of the company’s stock worth $451,000 after buying an additional 109 shares during the last quarter. 78.53% of the stock is currently owned by hedge funds and other institutional investors.

About Clorox

(Get Free Report)

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.

Further Reading